Equity · Healthcare
ABT
NYSEAbbott Laboratories (ABT)
The line runs $107.32 on 28 July through $103.70 on 23 October, on a scale from $90 to $120. Days the market did not trade hold the previous close, flat.
- Market cap
- $180.6B
- P/E (TTM)
- 29.1
- 52-week range
- $83 – $131
- Avg volume
- 493.4K
- Mentions, 30 days
- 96
- Net sentiment
- +0.04
as of Oct 23, 2026
Have Abbott Laboratories (ABT) insiders bought or sold shares recently?
In the 90 days to 27 Oct 2026, Abbott Laboratories insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 7 May 2026.
Form 4, 90 days to 27 Oct 2026, newest reported trade 2 Sep 2026
Buys 0Sells 3Net sold $46.85MOther filings 5
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Sep 2026 | MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLER | Sell | 27 | $3K |
| 25 Aug 2026 | Ford Robert BCHAIRMAN AND CEO | Sell | 398,832 | $46.20M |
| 11 Aug 2026 | Morrone Louis H.EXECUTIVE VICE PRESIDENT | Sell | 5,850 | $643K |
| Sold | 3 open-market sales | 404,709 | $46.85M |
5 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 23 Sep 2026 | Conroy Kevin TDirector | Tax withheld | 52,507 | $5.46M |
| 01 Sep 2026 | MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLER | Tax withheld | 52 | $6K |
| 01 Sep 2026 | Boudreau Philip PEVP AND CFO | Tax withheld | 388 | $43K |
| 25 Aug 2026 | Ford Robert BCHAIRMAN AND CEO | Option exercise | 398,832 | $21.55M |
| 12 Aug 2026 | Morrone Louis H.EXECUTIVE VICE PRESIDENT | Other | 12 | $1K |
Which funds hold Abbott Laboratories (ABT)?
15 of the 45 institutional funds we track reported a Abbott Laboratories position for the quarter ended 30 Jun 2026 — a combined $3.3B; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 8,597,227 | $780.1M | +348.7% |
| Two Sigma Investments | Added | 8,126,315 | $737.4M | +27.2% |
| Marshall Wace | Added | 5,542,438 | $502.9M | +175.6% |
| AQR Capital Management | Added | 4,193,058 | $380.5M | +166.6% |
| Millennium Management | Added | 3,599,994 | $326.7M | +172.0% |
| Point72 Asset Management | New position | 1,551,929 | $140.8M | |
| D. E. Shaw & Co. | Trimmed | 1,457,592 | $132.3M | −72.4% |
| Man Group | Added | 800,719 | $72.7M | +120.0% |
| Balyasny Asset Management | Held (±25%) | 740,808 | $67.2M | −12.3% |
| Tudor Investment Corp | Added | 730,332 | $66.3M | +123.9% |
Showing the 10 largest of 15 reported positions. The figures above count all of them.
Have members of Congress traded Abbott Laboratories (ABT)?
The most recent congressional trade disclosed in Abbott Laboratories is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 18 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 18 Sep 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | $1K–$15K | 24 days |
| 12 Jun 2026 | Richard McCormickhouse · Republican–GA | Purchase | $1K–$15K | 27 days |
| 24 Mar 2026 | Laura Friedmanhouse · Democrat–CA | Exchange | $1K–$15K | 24 days |
| 18 Dec 2025 | Julie Johnsonhouse · Democrat–TX | Sale | $1K–$15K | 28 days |
| 04 Dec 2025 | Byron Donaldshouse · Republican–FL | Sale | $1K–$15K | 34 days |
| 18 Nov 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | $1K–$15K | 27 days |
| 13 Nov 2025 | Julie Johnsonhouse · Democrat–TX | Sale | $1K–$15K | 28 days |
| 05 Nov 2025 | Richard McCormickhouse · Republican–GA | Purchase | $1K–$15K | 34 days |
What has been filed or recorded for Abbott Laboratories (ABT)?
The filings we hold for Abbott Laboratories, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 28 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 32 shares | $3K notional · <0.001% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 1 shares | $103 notional · <0.001% of shares out |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS $0.61 | Revenue $11.16B |
| 31 Mar 2026 | Financials | Total assets | $110.4B | at period end |
| 31 Mar 2026 | Financials | Total equity | $52.1B | at period end |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS $3.72 | Revenue $44.33B |
| 31 Dec 2025 | Financials | Revenue | $44.3B | fiscal year |
| 31 Dec 2025 | Financials | Net income | $6.5B | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | $3.72 | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS $0.94 | Revenue $11.37B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS $1.01 | Revenue $11.14B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS $0.76 | Revenue $10.36B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS $7.64 | Revenue $41.95B |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS $0.94 | Revenue $10.64B |
| 30 Jun 2024 | Quarterly earnings | Q2 2024 reported | EPS $0.74 | Revenue $10.38B |
What is Reddit saying about Abbott Laboratories (ABT)?
Reddit mentioned ABT 96 times in the 30 days to 26 October 2026, across 9 of the communities we track. All of them were scored for sentiment: 53% read bullish, 13% bearish and 34% neither. Reddit data updated 26 October 2026.
30-day window, Method
Mentions, 30 days 96Bullish 53%Bearish 13%Communities 9Against the market −1 point
How do Reddit mentions of Abbott Laboratories (ABT) compare with its price?
Share ↗
bullish
bullish
ABT reads 1 point less bullish than overall market sentiment. Same measure; same 30-day window.
Where Abbott Laboratories (ABT) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 86% | 83 | +0.04 |
| r/stocks | 5% | 5 | +0.04 |
| r/options | 2% | 2 | +0.04 |
| r/asx_bets | 1% | 1 | +0.16 |
| r/commodities | 1% | 1 | +0.11 |
| r/asx | 1% | 1 | +0.17 |
| r/investing | 1% | 1 | +0.07 |
| r/etfs | 1% | 1 | +0.05 |
| r/ausfinance | 1% | 1 | +0.10 |
Moves with Abbott Laboratories (ABT)
Tickers whose daily Reddit volume rose and fell with Abbott Laboratories (ABT)'s. Co-discussion, not price.
EZPZ +0.71ONON +0.65QQQS +0.64QQQ +0.62NOC +0.60DISCORD.PRV +0.59
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Abbott Laboratories (ABT): frequently asked questions
What did Abbott Laboratories shares close at?
Abbott Laboratories closed at $103.70 on 23 Oct 2026, up 1.08% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Abbott Laboratories’ market cap?
Abbott Laboratories is worth $180.6B by market value as of 23 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Abbott Laboratories’ P/E ratio?
Abbott Laboratories has a price-to-earnings ratio of 29.1, as of 23 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Abbott Laboratories’ revenue?
Abbott Laboratories reported revenue of $44.3B for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Abbott Laboratories insiders bought or sold shares recently?
In the 90 days to 27 Oct 2026, Abbott Laboratories insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 7 May 2026. A further 5 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Abbott Laboratories?
15 of the 45 funds we track reported a Abbott Laboratories position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Two Sigma Investments and Marshall Wace. See Funds
Have members of Congress traded Abbott Laboratories?
Yes. 49 trades in Abbott Laboratories appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 18 Sep 2026, filed 12 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Abbott Laboratories last report earnings?
Abbott Laboratories last reported earnings on 31 Mar 2026 for Q1 2026, with EPS of $0.61; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Abbott Laboratories?
Abbott Laboratories was mentioned 19 times in the last 7 days across the finance subreddits we track, and 96 times over the trailing 30 days. Of the 96 mentions scored for sentiment, 53% read bullish and 13% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 31 Mar 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings